259 related articles for article (PubMed ID: 32786098)
1. Calcineurin inhibitor (CNI)-associated skin cancers: New insights on exploring mechanisms by which CNIs downregulate DNA repair machinery.
Ume AC; Pugh JM; Kemp MG; Williams CR
Photodermatol Photoimmunol Photomed; 2020 Nov; 36(6):433-440. PubMed ID: 32786098
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation.
Yarosh DB; Pena AV; Nay SL; Canning MT; Brown DA
J Invest Dermatol; 2005 Nov; 125(5):1020-5. PubMed ID: 16297204
[TBL] [Abstract][Full Text] [Related]
3. The safety of calcineurin inhibitors for kidney-transplant patients.
Malvezzi P; Rostaing L
Expert Opin Drug Saf; 2015 Oct; 14(10):1531-46. PubMed ID: 26329325
[TBL] [Abstract][Full Text] [Related]
4. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin A-α suppression drives nuclear factor-κB-mediated NADPH oxidase-2 upregulation.
Cheriyan AM; Ume AC; Francis CE; King KN; Linck VA; Bai Y; Cai H; Hoover RS; Ma HP; Gooch JL; Williams CR
Am J Physiol Renal Physiol; 2021 May; 320(5):F789-F798. PubMed ID: 33615888
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin inhibitors: a double-edged sword.
Ume AC; Wenegieme TY; Williams CR
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F336-F341. PubMed ID: 33225712
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus.
Chakkera HA; Kudva Y; Kaplan B
Clin Pharmacol Ther; 2017 Jan; 101(1):114-120. PubMed ID: 27804122
[TBL] [Abstract][Full Text] [Related]
8. DNA repair in mononuclear cells: role of serine/threonine phosphatases.
Herman M; Ori Y; Chagnac A; Weinstein T; Korzets A; Zevin D; Malachi T; Gafter U
J Lab Clin Med; 2002 Oct; 140(4):255-62. PubMed ID: 12389024
[TBL] [Abstract][Full Text] [Related]
9. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.
Ori Y; Herman-Edelstein M; Zingerman B; Rozen-Zvi B; Gafter U; Malachi T; Gafter-Gvili A
Biomed Pharmacother; 2012 Sep; 66(6):409-13. PubMed ID: 22795807
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling.
Rodrigues-Diez R; González-Guerrero C; Ocaña-Salceda C; Rodrigues-Diez RR; Egido J; Ortiz A; Ruiz-Ortega M; Ramos AM
Sci Rep; 2016 Jun; 6():27915. PubMed ID: 27295076
[TBL] [Abstract][Full Text] [Related]
11. Individualizing calcineurin inhibitor therapy in renal transplantation--current limitations and perspectives.
Press RR; de Fijter JW; Guchelaar HJ
Curr Pharm Des; 2010; 16(2):176-86. PubMed ID: 20205663
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of ketoconazole combined with calmodulin inhibitor in solid organ transplantation: A systematic review and meta-analysis.
Xue T; Yang T; Chen C; Wu S; Li M; Ma L; Zhou Y; Cui Y
J Clin Pharm Ther; 2020 Feb; 45(1):29-34. PubMed ID: 31571253
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of cyclosporine A-Induced calcineurin isoform-specific matrix metalloproteinase 9 (MMP-9) in renal fibroblasts.
Francis CE; Bai Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):2549-2554. PubMed ID: 30007437
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus-induced hypomagnesemia and hypercalciuria requires FKBP12 suggesting a role for calcineurin.
Gratreak BDK; Swanson EA; Lazelle RA; Jelen SK; Hoenderop J; Bindels RJ; Yang CL; Ellison DH
Physiol Rep; 2020 Jan; 8(1):e14316. PubMed ID: 31908154
[TBL] [Abstract][Full Text] [Related]
15. Bioenergetic maladaptation and release of HMGB1 in calcineurin inhibitor-mediated nephrotoxicity.
Zmijewska AA; Zmijewski JW; Becker EJ; Benavides GA; Darley-Usmar V; Mannon RB
Am J Transplant; 2021 Sep; 21(9):2964-2977. PubMed ID: 33724664
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin Inhibitors Nephrotoxicity Prevention Strategies With Stress on Belatacept-Based Rescue Immunotherapy: A Review of the Current Evidence.
El Hennawy HM; Faifi ASA; El Nazer W; Mahedy A; Kamal A; Al Faifi IS; Abdulmalik H; Safar O; Zaitoun MF; Fahmy AE
Transplant Proc; 2021 Jun; 53(5):1532-1540. PubMed ID: 34020797
[TBL] [Abstract][Full Text] [Related]
17. The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.
Zhang X; Ji L; Yang L; Tang X; Qin W
Int Urol Nephrol; 2016 May; 48(5):731-43. PubMed ID: 26781720
[TBL] [Abstract][Full Text] [Related]
18. Longterm calcineurin inhibitor therapy and brain function in patients after liver transplantation.
Pflugrad H; Schrader AK; Tryc AB; Ding X; Lanfermann H; Jäckel E; Schrem H; Beneke J; Barg-Hock H; Klempnauer J; Weissenborn K
Liver Transpl; 2018 Jan; 24(1):56-66. PubMed ID: 29156491
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin inhibitors and male fertility after renal transplantation - a review.
Georgiou GK; Dounousi E; Harissis HV
Andrologia; 2016 Jun; 48(5):483-90. PubMed ID: 26341518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
